UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 1 trial in progress for in situ immunomodulation with CDX-301, radiation therapy, poly-ICLC, and CDX-1140 in patients with unresectable and metastatic solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS2697-TPS2697

2024

Volltextzugriff (PDF)

REFINE-Lung: A multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9145-TPS9145

2023

Volltextzugriff (PDF)

TAX-TORC: A phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2571-2571

2017

Volltextzugriff (PDF)

Expansion study of ADI-PEG 20, pemetrexed and cisplatin in patients with ASS1-deficient malignant pleural mesothelioma (TRAP)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.8553-8553

2017

Volltextzugriff (PDF)

18-FLT-PET/CT as an imaging biomarker in patients with ASS1-deficient thoracic cancers treated with ADI-PEG20, pemetrexed and cisplatin

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11567-11567

2016

Volltextzugriff (PDF)

Phase I study of abiraterone acetate (AA) in patients (pts) with estrogen receptor– (ER) or androgen receptor (AR) –positive advanced breast carcinoma resistant to standard endocrine therapies

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2525-2525

2011

Volltextzugriff (PDF)

Clinical characteristics of affected BRCA1 and BRCA2 mutation carriers in an underserved population

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1532-1532

2011

Volltextzugriff (PDF)

Predictors of pathologic response and correlation with long-term outcomes in a trial of neoadjuvant concurrent paclitaxel radiation in locally advanced breast cancer (LABC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.589-589

2010

Volltextzugriff (PDF)

A phase II, open-label study of ramucirumab (IMC-1121B), an IgG1 fully human monoclonal antibody (MAb) targeting VEGFR-2, in combination with paclitaxel and carboplatin as first-line therapy in patients (pts) with stage IIIb/IV non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7588-7588

2010

Volltextzugriff (PDF)

Five-year results of preoperative concurrent paclitaxel with radiation in locally advanced breast cancer (LABC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.567-567

2010

Volltextzugriff (PDF)

Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e13524-e13524

2009

Volltextzugriff (PDF)

A phase I study of daily BIBW 2992, an irreversible EGFR/HER-2 dual kinase inhibitor, in combination with weekly paclitaxel

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14541-e14541

2009

Volltextzugriff (PDF)

Magnetic Resonance Imaging quantification of breast density in BRCA carriers following gonadotropin releasing hormone agonist (GnRHA)-based hormonal chemoprevention

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1506-1506

2009

Volltextzugriff (PDF)

Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3024-3030

2007

Volltextzugriff (PDF)

Final results of a phase I study of wild-type oncolytic reovirus administered intravenously to patients with advanced cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3572-3572

2007

Volltextzugriff (PDF)

A phase Ib study of telatinib (BAY 57–9352), a VEGFR-2 inhibitor, in combination with docetaxel in patients with advanced solid tumours

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.14035-14035

2007

Volltextzugriff (PDF)

Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of a small molecule inhibitor of Poly ADP-Ribose Polymerase (PARP), KU-0059436 (Ku) in patients (p) with advanced tumours

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3022-3022

2006

Volltextzugriff (PDF)

A phase 1 dose finding study of CHR-2797, an inhibitor of M1 aminopeptidases, in patients with advanced solid tumours

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3053-3053

2006

Volltextzugriff (PDF)

Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), with docetaxel (D) in patients (p) with advanced cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3023-3023

2006

Volltextzugriff (PDF)

Treatment of Nonmetastatic Rhabdomyosarcoma in Childhood and Adolescence: Third Study of the International Society of Paediatric Oncology—SIOP Malignant Mesenchymal Tumor 89

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2618-2628

2005

Volltextzugriff (PDF)

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Journal of clinical oncology, 2003-03, Vol.21 (5), p.864-870

2003

Volltextzugriff (PDF)

Treatment of Children With Nonmetastatic Paratesticular Rhabdomyosarcoma: Results of the Malignant Mesenchymal Tumors Studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology

Journal of clinical oncology, 2003-03, Vol.21 (5), p.793-798

2003

Volltextzugriff (PDF)

Conservative Treatment for Girls With Nonmetastatic Rhabdomyosarcoma of the Genital Tract: A Report From the Study Committee of the International Society of Pediatric Oncology

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2117-2122

1999

Volltextzugriff (PDF)

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1318-1332

1997

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 1 trial in progress for in situ immunomodulation with CDX-301, radiation therapy, poly-ICLC, and CDX-1140 in patients with unresectable and metastatic solid tumors

REFINE-Lung: A multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design

TAX-TORC: A phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies

Expansion study of ADI-PEG 20, pemetrexed and cisplatin in patients with ASS1-deficient malignant pleural mesothelioma (TRAP)

18-FLT-PET/CT as an imaging biomarker in patients with ASS1-deficient thoracic cancers treated with ADI-PEG20, pemetrexed and cisplatin

Phase I study of abiraterone acetate (AA) in patients (pts) with estrogen receptor– (ER) or androgen receptor (AR) –positive advanced breast carcinoma resistant to standard endocrine therapies

Clinical characteristics of affected BRCA1 and BRCA2 mutation carriers in an underserved population

Predictors of pathologic response and correlation with long-term outcomes in a trial of neoadjuvant concurrent paclitaxel radiation in locally advanced breast cancer (LABC)

A phase II, open-label study of ramucirumab (IMC-1121B), an IgG1 fully human monoclonal antibody (MAb) targeting VEGFR-2, in combination with paclitaxel and carboplatin as first-line therapy in patients (pts) with stage IIIb/IV non-small cell lung cancer (NSCLC)

Five-year results of preoperative concurrent paclitaxel with radiation in locally advanced breast cancer (LABC)

Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies

A phase I study of daily BIBW 2992, an irreversible EGFR/HER-2 dual kinase inhibitor, in combination with weekly paclitaxel

Magnetic Resonance Imaging quantification of breast density in BRCA carriers following gonadotropin releasing hormone agonist (GnRHA)-based hormonal chemoprevention

Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer

Final results of a phase I study of wild-type oncolytic reovirus administered intravenously to patients with advanced cancer

A phase Ib study of telatinib (BAY 57–9352), a VEGFR-2 inhibitor, in combination with docetaxel in patients with advanced solid tumours

Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of a small molecule inhibitor of Poly ADP-Ribose Polymerase (PARP), KU-0059436 (Ku) in patients (p) with advanced tumours

A phase 1 dose finding study of CHR-2797, an inhibitor of M1 aminopeptidases, in patients with advanced solid tumours

Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), with docetaxel (D) in patients (p) with advanced cancer

Treatment of Nonmetastatic Rhabdomyosarcoma in Childhood and Adolescence: Third Study of the International Society of Paediatric Oncology—SIOP Malignant Mesenchymal Tumor 89

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Treatment of Children With Nonmetastatic Paratesticular Rhabdomyosarcoma: Results of the Malignant Mesenchymal Tumors Studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology

Conservative Treatment for Girls With Nonmetastatic Rhabdomyosarcoma of the Genital Tract: A Report From the Study Committee of the International Society of Pediatric Oncology

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer

Aktive Filter

Suchergebnisse filtern